BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Son DS, Lee ES, Adunyah SE. The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs. Immune Netw 2020;20:e29. [PMID: 32895616 DOI: 10.4110/in.2020.20.e29] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Choi HS, Ko YS, Jin H, Kang KM, Ha IB, Jeong H, Song HN, Kim HJ, Jeong BK. Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro. Molecules 2021;26:5118. [PMID: 34500557 DOI: 10.3390/molecules26175118] [Reference Citation Analysis]
2 Laxmikeshav K, Himaja A, Shankaraiah N. Exploration of benzimidazoles as potential microtubule modulators: An insight in the synthetic and therapeutic evolution. Journal of Molecular Structure 2022;1253:132251. [DOI: 10.1016/j.molstruc.2021.132251] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Hegazy SK, El-Azab GA, Zakaria F, Mostafa MF, El-Ghoneimy RA. Mebendazole; from an anti-parasitic drug to a promising candidate for drug repurposing in colorectal cancer. Life Sci 2022;:120536. [PMID: 35385794 DOI: 10.1016/j.lfs.2022.120536] [Reference Citation Analysis]
4 Prasher P, Sharma M. Benzimidazole-carbamate anthelmintics: Perspective candidates for the anticancer drug development. Drug Dev Res 2022. [PMID: 35297083 DOI: 10.1002/ddr.21933] [Reference Citation Analysis]
5 Florio R, Carradori S, Veschi S, Brocco D, Di Genni T, Cirilli R, Casulli A, Cama A, De Lellis L. Screening of Benzimidazole-Based Anthelmintics and Their Enantiomers as Repurposed Drug Candidates in Cancer Therapy. Pharmaceuticals (Basel) 2021;14:372. [PMID: 33920661 DOI: 10.3390/ph14040372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chen C, Ding Y, Liu H, Sun M, Wang H, Wu D. Flubendazole Plays an Important Anti-Tumor Role in Different Types of Cancers. Int J Mol Sci 2022;23:519. [PMID: 35008943 DOI: 10.3390/ijms23010519] [Reference Citation Analysis]
7 Chai JY, Jung BK, Hong SJ. Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update. Korean J Parasitol 2021;59:189-225. [PMID: 34218593 DOI: 10.3347/kjp.2021.59.3.189] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Küçükbay H, Uçkun M, Apohan E, Yeşilada Ö. Cytotoxic and antimicrobial potential of benzimidazole derivatives. Arch Pharm (Weinheim) 2021;354:e2100076. [PMID: 33872394 DOI: 10.1002/ardp.202100076] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Peng Y, Pan J, Ou F, Wang W, Hu H, Chen L, Zeng S, Zeng K, Yu L. Fenbendazole and its synthetic analog interfere with HeLa cells’ proliferation and energy metabolism via inducing oxidative stress and modulating MEK3/6-p38-MAPK pathway. Chemico-Biological Interactions 2022;361:109983. [DOI: 10.1016/j.cbi.2022.109983] [Reference Citation Analysis]
10 Yi H, Liang L, Wang H, Luo S, Hu L, Wang Y, Shen X, Xiao L, Zhang Y, Peng H, Dai C, Yuan L, Li R, Gong F, Li Z, Ye M, Liu J, Zhou H, Zhang J, Xiao X. Albendazole inhibits NF-κB signaling pathway to overcome tumor stemness and bortezomib resistance in multiple myeloma. Cancer Lett 2021;520:307-20. [PMID: 34390764 DOI: 10.1016/j.canlet.2021.08.009] [Reference Citation Analysis]
11 Amahong K, Yan M, Li J, Yang N, Liu H, Bi X, Vuitton DA, Lin R, Lü G. EgGLUT1 Is Crucial for the Viability of Echinococcus granulosus sensu stricto Metacestode: A New Therapeutic Target? Front Cell Infect Microbiol 2021;11:747739. [PMID: 34858873 DOI: 10.3389/fcimb.2021.747739] [Reference Citation Analysis]
12 Elmaaty AA, Darwish KM, Chrouda A, Boseila AA, Tantawy MA, Elhady SS, Shaik AB, Mustafa M, Al-Karmalawy AA. In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity. ACS Omega 2022;7:875-99. [PMID: 35036753 DOI: 10.1021/acsomega.1c05519] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
13 De Lellis L, Veschi S, Tinari N, Mokini Z, Carradori S, Brocco D, Florio R, Grassadonia A, Cama A. Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates. Cancers (Basel) 2021;13:3946. [PMID: 34439102 DOI: 10.3390/cancers13163946] [Reference Citation Analysis]
14 Hernández-romero D, Rosete-luna S, López-monteon A, Chávez-piña A, Pérez-hernández N, Marroquín-flores J, Cruz-navarro A, Pesado-gómez G, Morales-morales D, Colorado-peralta R. First-row transition metal compounds containing benzimidazole ligands: An overview of their anticancer and antitumor activity. Coordination Chemistry Reviews 2021;439:213930. [DOI: 10.1016/j.ccr.2021.213930] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
15 Park D. Fenbendazole Suppresses Growth and Induces Apoptosis of Actively Growing H4IIE Hepatocellular Carcinoma Cells via p21-Mediated Cell-Cycle Arrest. Biol Pharm Bull 2022;45:184-93. [PMID: 35110505 DOI: 10.1248/bpb.b21-00697] [Reference Citation Analysis]
16 He Z, Lei S, Liang F, Tan L, Zhang W, Xie L, Zheng H, Lu Y. Low-Dose Albendazole Inhibits Epithelial-Mesenchymal Transition of Melanoma Cells by Enhancing Phosphorylated GSK-3β/Tyr216 Accumulation. J Oncol 2021;2021:4475192. [PMID: 34966427 DOI: 10.1155/2021/4475192] [Reference Citation Analysis]
17 Alavi SE, Ebrahimi Shahmabadi H. Anthelmintics for drug repurposing: Opportunities and challenges. Saudi Pharm J 2021;29:434-45. [PMID: 34135669 DOI: 10.1016/j.jsps.2021.04.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Cerrito MG, Grassilli E. Identifying Novel Actionable Targets in Colon Cancer. Biomedicines 2021;9:579. [PMID: 34065438 DOI: 10.3390/biomedicines9050579] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Montecinos F, Loew M, Chio TI, Bane SL, Sackett DL. Interaction of Colchicine-Site Ligands With the Blood Cell-Specific Isotype of β-Tubulin—Notable Affinity for Benzimidazoles. Front Cell Dev Biol 2022;10:884287. [DOI: 10.3389/fcell.2022.884287] [Reference Citation Analysis]
20 Esfahani MKM, Islam N, Cabot PJ, Izake EL. Development of Thiabendazole-Loaded Mesoporous Silica Nanoparticles for Cancer Therapy. ACS Biomater Sci Eng 2021. [PMID: 34056895 DOI: 10.1021/acsbiomaterials.1c00066] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 de Oliveira HC, Rodrigues ML. Repurposing benzimidazoles to fight Cryptococcus. Fungal Biology Reviews 2021;37:27-40. [DOI: 10.1016/j.fbr.2021.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]